Page last updated: 2024-12-05

benzene 1,2,3-tricarboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Benzene-1,2,3-tricarboxylic acid, also known as trimellitic acid, is a white solid organic compound with the formula C9H6O6. It is a tribasic acid, meaning it has three carboxylic acid groups. The molecule is a benzene ring with three carboxyl groups attached to the ring. It is an important industrial chemical, used in the production of plasticizers, resins, and other polymers. It is also used as a starting material for the synthesis of various pharmaceuticals and agrochemicals. The compound is synthesized by the oxidation of 1,2,3-trimethylbenzene or by the hydrolysis of trimellitic anhydride. Trimellitic acid is a weak acid, and it is soluble in water. It is also a good chelating agent, meaning it can bind to metal ions. This property makes it useful in various applications, including metal plating and water treatment. Research on this compound focuses on its synthesis, its applications in the production of polymers and other chemicals, and its potential environmental impact. For example, studies have been conducted to investigate its potential for use in the synthesis of biodegradable polymers. Trimellitic acid is also a precursor to the synthesis of other important compounds, such as trimellitic anhydride, a key monomer for the production of unsaturated polyester resins. The compound's importance lies in its versatility and potential to be used in a variety of applications. '

benzene 1,2,3-tricarboxylic acid: structure given in first source; inhibits phosphoenolpyruvate carboxykinase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11288
CHEMBL ID1161013
SCHEMBL ID23288
MeSH IDM0045301

Synonyms (49)

Synonym
AC-12649
benzene-1,2,3-tricarboxylic acid
1,2,3-benzenetricarboxylic acid ,
569-51-7
nsc401092
1,3-tricarboxybenzene
1,3-benzenetricarboxylic acid
nsc-401092
hemimellitic acid
inchi=1/c9h6o6/c10-7(11)4-2-1-3-5(8(12)13)6(4)9(14)15/h1-3h,(h,10,11)(h,12,13)(h,14,15
B0801
CHEMBL1161013
benzene-1,2,3-tricarboxylatehemimellitic acid
A831252
NCGC00248891-01
1,2,3-tribenzoic acid
dsstox_gsid_21486
dsstox_cid_1486
dsstox_rid_76180
NCGC00258532-01
cas-36362-97-7
tox21_200979
benzenetricarboxylic acid
einecs 209-317-0
nsc 401092
1,2,3-tricarboxybenzene
benzene 1,2,3-tricarboxylic acid
cku8ptz7m8 ,
unii-cku8ptz7m8
FT-0606212
AKOS015889415
AM1084
1,2,3-benzenetricarboxylate
gtpl4701
SCHEMBL23288
H1592
benzene tricarboxylic acid
mfcd00002468
SY017131
3gq ,
W-105495
GS-3056
Q27070757
DTXSID901018142
benzene-1,2,3-tricarboxylicacid
EN300-137827
YSWG650
CS-0157247
PD051925
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency27.55610.000657.913322,387.1992AID1259377
progesterone receptorHomo sapiens (human)Potency30.91850.000417.946075.1148AID1346784
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency56.06770.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency24.78160.000817.505159.3239AID1159527
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency69.21790.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID127482Ability to bind to monoclonal antibody IgE (Lb4), expressed as association constant (LogKA)1996Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
Comparative molecular field analysis of haptens docked to the multispecific antibody IgE(Lb4)
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (36.84)18.7374
1990's4 (21.05)18.2507
2000's2 (10.53)29.6817
2010's6 (31.58)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.97 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.43 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]